Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia.
Kairu XieHairong XiongWen XiaoZhiyong XiongWenjun HuJiaxin YeNing XuJian ShiChangfei YuanZhixian ChenDaojia MiaoXiaoping ZhangHongmei YangPublished in: Cancer cell international (2021)
The findings indicated that miR-29c was negatively correlated with the cachectic phenotype, and the miR-29c-LIF axis is a potential therapeutic target for cancer cachexia.